← FDA Drug Approvals (Drugs@FDA)

KYNAMRO

NDA · New Drug Application · Sponsor: KASTLE THERAPS LLC · Approved 2013-01-29

Drug application

FDA Application #

NDA203568

Application type

New Drug Application

Brand name

KYNAMRO

Generic name

Mipomersen Sodium

Active ingredients

MIPOMERSEN SODIUM

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

KASTLE THERAPS LLC

First approval

2013-01-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown